Azalea Ovarian cancer is generally difficult to cure, but early diagnosis and standardized treatment can achieve long-term survival. The treatment effect of ovarian cancer is mainly related to the stage, pathological type and treatment plan.
Patients with early-stage ovarian cancer, whose tumors are limited to the ovary or pelvic cavity, can have a better prognosis through comprehensive surgical resection combined with chemotherapy. Surgery requires removal of bilateral appendages, uterus, omentum, and metastatic lesions in the pelvic and abdominal cavity, supplemented by lymph node dissection if necessary. Postoperative platinum-based combined with paclitaxel chemotherapy can eliminate residual cancer cells. At this time, the five-year survival rate is relatively high, and some patients can achieve clinical cure standards. Patients require lifelong follow-up to monitor tumor markers and imaging changes.
In mid-to-late stage ovarian cancer, due to tumor spread to the abdominal cavity or distant organs, complete resection is difficult and prone to recurrence and metastasis. Even after cytoreductive surgery and multiple courses of chemotherapy, most patients will still experience recurrence and require repeated treatments. At this time, the treatment goal shifts to prolonging progression-free survival and improving quality of life. Some patients can obtain longer-term remission through maintenance therapy with targeted drugs such as PARP inhibitors.
Patients need to maintain a low-fat and high-protein diet after surgery and supplement vitamins and minerals appropriately. Perform regular pelvic examinations, ultrasounds and CA125 tests, and seek medical advice promptly if symptoms such as abdominal distension and pain occur. It is recommended to join a mutual aid organization for patients and relieve anxiety through psychological counseling.
